Table III.
Clinical, sociodemographic and psychosocial factors and their association with considering side effects as a main factor in treatment preference
| Odds Ratio | p | |
|---|---|---|
| Age | 1.00 | 0.639 |
| PSA | 0.99 | 0.558 |
| Gleason Score | ||
| ≤6 | NA | |
| 7 | 0.63 | 0.032 |
| 8–10 | 0.38 | 0.016 |
| Race | ||
| Non black | NA | |
| Black | 0.90 | 0.751 |
| Number of chronic conditions | 0.92 | 0.424 |
| Currently Married | 0.92 | 0.732 |
| Education | ||
| Less than College | NA | |
| College or Graduate degree | 1.40 | 0.085 |
| Returned Survey After Starting Treatment | 0.42 | <0.001 |
| Study Site | ||
| Kaiser Permanente Northern California (KPNC) | NA | |
| USC | 1.15 | 0.655 |
| Pacific Northwest | 0.83 | 0.518 |
| No. of Doctors Consulteda | 1.43 | 0.006 |
| No. of Treatment Options Recommended | 1.05 | 0.556 |
| Worry and Anxiety about Cancer | ||
| Low Worry and Anxiety | NA | |
| Moderate Worry and Anxiety | 1.57 | 0.083 |
| High Worry and Anxiety | 1.33 | 0.271 |
| Feeling of Control Scale | ||
| High Feeling of Control | NA | |
| Moderate Feeling of Control | 1.00 | 0.988 |
| Low Feeling of Control | 1.32 | 0.322 |
| Current Limitations in Urinary Function | 0.84 | 0.382 |
| Current Limitations in Bowel Function | 0.85 | 0.469 |
| Ability To Have an Erection (Good or Very Good) | 0.57 | 0.007 |
| R-Square = 0.050 | ||
a
Greater number of doctors consulted was associated with greater likelihood of considering adverse effects
NA = not available; PSA = prostate-specific antigen